Cite
HARVARD Citation
Seban, R. et al. (2021). Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung cancer. pp. 45-55. [Online].